Search results for "Type 1 diabetes"
Standard blood glucose targets are lower than HbA1c goals require
A recent study determined the pre- and postprandial blood glucose levels that should be targeted to reach a specific HbA1c goal in patients with type 1 or type 2 diabetes.
https://immattersacp.org/weekly/archives/2014/02/25/1.htm
25 Feb 2014
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
MKSAP Quiz: routine follow-up visit for diabetes and hyperlipidemia
A 59-year-old woman is evaluated during a routine follow-up visit. She was recently diagnosed with type 2 diabetes mellitus and hyperlipidemia. She feels well. Medications are metformin, atorvastatin, and aspirin. Following a physical exam and lab results, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2014/03/11/3.htm
11 Mar 2014
MKSAP Quiz: 3-week history of painful muscle spasms and twisting movements
A 24-year-old woman is evaluated for a 3-week history of painful muscle spasms and twisting movements in the neck and trunk. She says that her neck feels as if it is being pulled backward. She also reports general restlessness and an inability to keep still. Her medical history is notable for asthma, type 1 diabetes mellitus, and gastroparesis with reflux. The patient has no family history of neuropsychiatric disorders or liver disease. Medications are albuterol, insulin, omeprazole, and metoclopramide. Following findings from a physical exam, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2014/03/18/3.htm
18 Mar 2014
Comorbid conditions associated with increased herpes zoster risk in younger patients
A range of conditions were associated with an increased risk of herpes zoster, especially immunosuppressive conditions, and the increased risk was greater in younger age groups, a study found.
https://immattersacp.org/weekly/archives/2014/05/20/5.htm
20 May 2014
New recommendations on insulin pump use
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology offered guidance on optimal and safe use of insulin pumps in a new consensus statement.
https://immattersacp.org/weekly/archives/2014/06/03/5.htm
3 Jun 2014
New drugs for diabetes, secondary prevention of CV events
This update covers approval of a new drug to treat type 2 diabetes mellitus, along with diet and exercise, and of a drug to reduce risk of heart attack, stroke, cardiovascular death, and need for revascularization in patients with a previous heart attack or peripheral artery disease.
https://immattersacp.org/archives/2014/07/fda.htm
1 Jul 2014
MKSAP Quiz: 8-month history of crampy abdominal pain, loose bowel movements
A 42-year-old woman is evaluated for an 8-month history of crampy abdominal pain and three loose bowel movements per day. The pain is relieved by a bowel movement. There are no nocturnal bowel movements, and there is no blood or dark tarry material in the stool. She has not had fever, night sweats, or weight loss. She has a history of Hashimoto disease and is treated with levothyroxine. Following a physical exam, rectal exam, and lab tests, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2014/08/26/3.htm
26 Aug 2014
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
SGLT2 inhibitors change glucose dynamic
The kidney's role in glucose production is as a producer and consumer of it, as well as filtering and reabsorbing it. SGLT2 inhibitors change that dynamic, creating new mechanisms, benefits and risks, and uncertainties that internists should know about this new drug class.
https://immattersacp.org/archives/2015/02/sglt2.htm
1 Feb 2015